Trial Profile

Comparative effects on nocturnal hypertension at home by combination therapy of ARB/CCB and ARB/diuretics

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 16 Jan 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amlodipine/irbesartan (Primary) ; Irbesartan/trichlormethiazide (Primary)
Indications Hypertension
Focus Therapeutic Use
Acronyms NOCTURNE

Most Recent Events

29 Sep 2016 Status changed from active, no longer recruiting to completed, as per results presented at the 26th Scientific Meeting of the International Society of Hypertension
29 Sep 2016 Preliminary results presented at the 26th Scientific Meeting of the International Society of Hypertension
25 May 2016 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com